<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, the first joint paediatric regulatory action was taken by the ICH (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), an organization working on harmonizing drug regulation requirements between the EU, Japan and the US. In July 2000 Guideline E11 (R1) was published: Clinical investigation of medicinal products in the paediatric population, with the final version in August 2017 [
 <xref rid="B9-pharmaceutics-13-00387" ref-type="bibr">9</xref>].
</p>
